Arexvy RSV Vaccine Expansion: Broader Access an...

By HEOR Staff Writer

December 15, 2025

CHMP Backs Arexvy RSV Vaccine Expansion for All Adults 18+ The Arexvy RSV vaccine expansion has received a positive recommendation from the European Medicines Agency's Commit...
Provisional Agreement on EU Pharmaceutical Reform: Boosting Innovation and Co...
2025 China Drug Catalog Boosts Access with 114 New Drugs and Innovative Solut...
NICE Approves Seven Digital Cardiac Rehabilitation Technologies for Enhanced ...
Repurposing Off-Patent Medicines: Insights from the EU Pilot Initiative
Innovations in Haematology Cell Therapy at ASH 2025
WHO Guidelines Set New Standard for GLP-1 Obesity Therapies in Adults
Advancements in Continuous Glucose Monitoring for Type 2 Diabetes Management
GLP-1RAs Psychiatric Care: Transforming Metabolic Management for Psychotropic...
NICE Endorses Obecabtagene Autoleucel Therapy for Adult Relapsed B-Cell Leuka...
Accelerating Access to Latin America Innovative Therapies Through Collaborati...
Addressing AI Polyp Detection Gaps: A Roadmap for Evidence Generation and NHS...
Health Investment Returns: Harnessing Health as a Strategic Economic Asset